Celltrion Inc

Celltrion Inc company information, Employees & Contact Information

Explore related pages

Related company profiles:

Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9

Company Details

Employees
1.62K
Address
4f, 19, Academy-Ro 51, Yeonsu-Gu, Incheon, Korea 22014, Incheon,406-081,korea, Republic Of
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Incheon
Looking for a particular Celltrion Inc employee's phone or email?

Celltrion Inc Questions

News

Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger - Business Wire

Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger Business Wire

Yuflyma, a Citrate-Free, High-Concentration Biosimilar to Humira, Gets FDA Approval - Medical Professionals Reference

Yuflyma, a Citrate-Free, High-Concentration Biosimilar to Humira, Gets FDA Approval Medical Professionals Reference

Celltrion Celebrates a Decade of Biosimilar Innovation in Europe - Business Wire

Celltrion Celebrates a Decade of Biosimilar Innovation in Europe Business Wire

Celltrion Healthcare receives Health Canada marketing authorization for world's first subcutaneous formulation of infliximab, Remsima™ SC, for the treatment of people with rheumatoid arthritis - PR Newswire Canada

Celltrion Healthcare receives Health Canada marketing authorization for world's first subcutaneous formulation of infliximab, Remsima™ SC, for the treatment of people with rheumatoid arthritis PR Newswire Canada

Celltrion Healthcare launches Remsima™ SC, the world's first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis - PR Newswire Canada

Celltrion Healthcare launches Remsima™ SC, the world's first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis PR Newswire Canada

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant